Media Summary: Based on case studies presented in 00:00: Intro to Jeffrey Weber, M.D., Ph.D., explains what " Dr. Dan Chen explains how immunotherapy may affect the PD-L1/

Kto Pd 1 Using Data - Detailed Analysis & Overview

Based on case studies presented in 00:00: Intro to Jeffrey Weber, M.D., Ph.D., explains what " Dr. Dan Chen explains how immunotherapy may affect the PD-L1/ David R. Gandara, MD, director, Thoracic Oncology Program, and professor, UC Davis Comprehensive Cancer Center, discusses ... Cassian Yee, MD, MD Anderson Cancer Center, The University of Texas, Houston, TX, discusses the combination of This Harvard Medical School Continuing Education video examines these key questions: How do immune checkpoint inhibitors ...

Emmanuel Antonarakis, MBBCh, of Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, speaks at the 2019 ... Winners of the 2014 William B. Coley Award for Distinguished Research in Tumor Immunology discuss their contributions to the ... How does immunotherapy fight cancer? If you take the brakes off the immune system, you can unleash an attack on cancer cells. Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, ...

Photo Gallery

KtO PD 1 Using Data Multiple Measures 11 2 12
Exploring the PD-1/PD-L1 pathway using Data, Tools, and Resources from RCSB.org
What is PD-1? Ask a Scientist
PD-L1/PD-1 Pathway: A Security Checkpoint
Combining CTLA-4 Agents With PD-1/PD-L1 Agents in Lung Cancer
PD-1 and OX40: potential PDAC combination therapy
Cancer Immune Checkpoint Inhibitors
Predicting PD-1 checkpoint inhibitor sensitivity in prostate cancer: potential molecular biomarkers
PD1/ CTLA4 : Upfront or sequentially?
Discovering the PD-1 Checkpoint: Winners of the 2014 William B. Coley Award for Tumor Immunology
How is Immunotherapy Used to Fight Cancer? | Dana-Farber Cancer Institute | Science Illustrated
PD-1-Blocking Antibodies Bound to T Cells Monitoring | Protocol Preview
View Detailed Profile
KtO PD 1 Using Data Multiple Measures 11 2 12

KtO PD 1 Using Data Multiple Measures 11 2 12

30 minute webcast of

Exploring the PD-1/PD-L1 pathway using Data, Tools, and Resources from RCSB.org

Exploring the PD-1/PD-L1 pathway using Data, Tools, and Resources from RCSB.org

Based on case studies presented in http://doi.org/10.1002/pro.4482 00:00: Intro to

What is PD-1? Ask a Scientist

What is PD-1? Ask a Scientist

Jeffrey Weber, M.D., Ph.D., explains what "

PD-L1/PD-1 Pathway: A Security Checkpoint

PD-L1/PD-1 Pathway: A Security Checkpoint

Dr. Dan Chen explains how immunotherapy may affect the PD-L1/

Combining CTLA-4 Agents With PD-1/PD-L1 Agents in Lung Cancer

Combining CTLA-4 Agents With PD-1/PD-L1 Agents in Lung Cancer

David R. Gandara, MD, director, Thoracic Oncology Program, and professor, UC Davis Comprehensive Cancer Center, discusses ...

PD-1 and OX40: potential PDAC combination therapy

PD-1 and OX40: potential PDAC combination therapy

Cassian Yee, MD, MD Anderson Cancer Center, The University of Texas, Houston, TX, discusses the combination of

Cancer Immune Checkpoint Inhibitors

Cancer Immune Checkpoint Inhibitors

This Harvard Medical School Continuing Education video examines these key questions: How do immune checkpoint inhibitors ...

Predicting PD-1 checkpoint inhibitor sensitivity in prostate cancer: potential molecular biomarkers

Predicting PD-1 checkpoint inhibitor sensitivity in prostate cancer: potential molecular biomarkers

Emmanuel Antonarakis, MBBCh, of Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, speaks at the 2019 ...

PD1/ CTLA4 : Upfront or sequentially?

PD1/ CTLA4 : Upfront or sequentially?

Prof Hoeller speaks

Discovering the PD-1 Checkpoint: Winners of the 2014 William B. Coley Award for Tumor Immunology

Discovering the PD-1 Checkpoint: Winners of the 2014 William B. Coley Award for Tumor Immunology

Winners of the 2014 William B. Coley Award for Distinguished Research in Tumor Immunology discuss their contributions to the ...

How is Immunotherapy Used to Fight Cancer? | Dana-Farber Cancer Institute | Science Illustrated

How is Immunotherapy Used to Fight Cancer? | Dana-Farber Cancer Institute | Science Illustrated

How does immunotherapy fight cancer? If you take the brakes off the immune system, you can unleash an attack on cancer cells.

PD-1-Blocking Antibodies Bound to T Cells Monitoring | Protocol Preview

PD-1-Blocking Antibodies Bound to T Cells Monitoring | Protocol Preview

Watch the Full Video at ...

Exploring the Combination Anti-CTLA-4 and Anti-PD-1 in Multiple Myeloma Post-Transplant

Exploring the Combination Anti-CTLA-4 and Anti-PD-1 in Multiple Myeloma Post-Transplant

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, ...